Physician profile
Thomas Albert Ricks
NPI 1396205357
$11,520.47
in general payments reported to CMS, 2019-2025
9 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $10K · 2023: $1,186 · 2024: $81.63 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $934 · Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $934.17 |
| Food and Beverage | $481.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $1,106.08 | 2023-2025 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $198.78 | 2022-2025 | Durolane, Xcell, Exogen Ultrasound Bone Healing System |
| Amgen INC. | $71.42 | 2024-2025 | Evenity, Prolia, Prolia |
| Djo, LLC | $38.89 | 2023 | Donjoy, Aircast |
| Prime Surgical, LLC | $31.22 | 2023 | |
| Spr Therapeutics, INC | $26.69 | 2024 | Sprint Pns System |
| Depuy Synthes Sales INC. | $24.13 | 2024 | Orthovisc, Monovisc |
| Stryker Corporation | $23.26 | 2023 | Mako |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.